Desmoteplase for Acute Ischemic Stroke within 3 to 9 Hours after Symptom Onset: Evidence from Randomized Controlled Trials

Recent studies have shown inconsistent results regarding the value of desmoteplase for treating acute ischemic stroke (AIS) when administered within an extended time window. We performed a meta-analysis to explore the value of desmoteplase in AIS treatment. The MEDLINE, EMBASE, and Cochrane Library...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ligen, Liang, Feng, Li, Yunping, Shao, Anwen, Zhou, Keren, Yu, Jun, Zhang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037417/
https://www.ncbi.nlm.nih.gov/pubmed/27671010
http://dx.doi.org/10.1038/srep33989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037417/
https://www.ncbi.nlm.nih.gov/pubmed/27671010
http://dx.doi.org/10.1038/srep33989

Ejemplares similares